Drug-induced exacerbations of porphyria.
D000477:Alkylating Agents / Q000009:adverse effects; D000700:Analgesics / Q000009:adverse effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D002642:Chick Embryo; D004195:Disease Models, Animal; D006418:Heme / Q000096:biosynthesis; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007004:Hypoglycemic Agents / Q000009:adverse effects; D008099:Liver / Q000378:metabolism; D011164:Porphyrias / Q000139:chemically induced* / Q000378:metabolism; D011619:Psychotropic Drugs / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects
D000477:Alkylating Agents; D000700:Analgesics; D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D000959:Antihypertensive Agents; D000697:Central Nervous System Stimulants; D006993:Hypnotics and Sedatives; D007004:Hypoglycemic Agents; D011619:Psychotropic Drugs; D014149:Tranquilizing Agents; D006418:Heme